Compounds > 2-nitro-4-carboxyphenyl-n,n-diphenylcarbamate
Page last updated: 2024-10-21

2-nitro-4-carboxyphenyl-n,n-diphenylcarbamate and Hypertension

2-nitro-4-carboxyphenyl-n,n-diphenylcarbamate has been researched along with Hypertension in 1 studies

2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate: inhibits phospholipase C and serine esterases; structure in first source

Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tostes, RC1
Storm, DS1
Chi, DH1
Webb, RC1

Other Studies

1 other study available for 2-nitro-4-carboxyphenyl-n,n-diphenylcarbamate and Hypertension

ArticleYear
Intracellular calcium stores and oscillatory contractions in arteries from genetically hypertensive rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 1996, Volume: 19, Issue:2

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e

1996